PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Net Current Asset Value : Rp0.00 (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

PT Diagnos Laboratorium Utama Tbk's net current asset value per share for the quarter that ended in . 20 was Rp0.00.

The historical rank and industry rank for PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value or its related term are showing as below:

ISX:DGNS's Price-to-Net-Current-Asset-Value is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 4.18
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

PT Diagnos Laboratorium Utama Tbk Net Current Asset Value Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk Net Current Asset Value Chart

PT Diagnos Laboratorium Utama Tbk Annual Data

Trend

Net Current Asset Value

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data

Net Current Asset Value

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Diagnos Laboratorium Utama Tbk's Price-to-Net-Current-Asset-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's Price-to-Net-Current-Asset-Value falls into.

Save Embed

;

Save Embed

;

PT Diagnos Laboratorium Utama Tbk Net Current Asset Value Calculation

PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value (NCAV) per share for the fiscal year that ended in . 20 is calculated as

	Net Current Asset Value Per Share		(A: . 20 )
=	(Total Current Assets	-	Total Liabilities	-	Minority Interest	-	Preferred Stock)	/	Shares Outstanding (EOP)
=	(	-	N/A	-		-	)	/	0
=	N/A

PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value (NCAV) per share for the quarter that ended in . 20 is calculated as

	Net Current Asset Value Per Share		(Q: . 20 )
=	(Total Current Assets	-	Total Liabilities	-	Minority Interest	-	Preferred Stock)	/	Shares Outstanding (EOP)
=	(	-	N/A	-		-	)	/	0
=	N/A

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.

PT Diagnos Laboratorium Utama Tbk Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Diagnos Laboratorium Utama Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » Net Current Asset Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350

Website

https://www.diagnos.co.id

PT Diagnos Laboratorium Utama Tbk provides laboratory services that include health support service activities that are managed by both the government and the private sector, such as health laboratories. The business products and services include Clinical Pathology Laboratory, Anatomy Pathology Laboratory, Genomic Laboratory, Homecare Health Services, and Corporate Health Service.